The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Danilova N.V.

Lomonosov Moscow State University

Mikhailov I.A.

Center for Expertise and Quality Control of Medical Care;
Lomonosov Moscow State University

Oleynikova N.A.

Lomonosov Moscow State University

Polushkina T.V.

Lomonosov Moscow State University

E-cadherin expression in tumor emboli in gastric cancer

Authors:

Danilova N.V., Mikhailov I.A., Oleynikova N.A., Polushkina T.V.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2021;83(3): 11‑19

DOI: 10.17116/patol20218303111

Read: 2819 times

Download PDF (RU)
Contact the author
Table of contents

E-CADHERIN EXPRESSION IN TUMOR EMBOLI IN GASTRIC CANCER
E-CADHERIN EXPRESSION IN TUMOR EMBOLI IN GASTRIC CANCER

To cite this article:

Danilova NV, Mikhailov IA, Oleynikova NA, Polushkina TV. E-cadherin expression in tumor emboli in gastric cancer. Russian Journal of Archive of Pathology. 2021;83(3):11‑19. (In Russ.)
https://doi.org/10.17116/patol20218303111

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

OBJECTIVE

To determine the level of E-cadherin expression in tumor emboli, to compare it with expression in a tumor, to determine the dependence of E-cadherin expression in tumor emboli on the clinical and morphological characteristics of gastric cancer.

MATERIAL AND METHODS

We used samples of surgical material from 280 patients with a verified diagnosis of gastric cancer. E-cadherin expression was determined by immunohistochemical method. The results of the reactions were assessed semi-quantitatively and compared with the main clinical and morphological characteristics of gastric cancer (histological type according to the WHO classification 2019, histological type according to the classification of P. Lauren, clinical stage, depth of invasion (T), number of metastases in lymph nodes (N), presence or/absence of distant metastases (M), tumor localization in the stomach).

RESULTS

Among 280 cases of cancer, emboli were detected only in 67 cases, used for further analysis. The rest of the samples were excluded from the analysis, since emboli did not get into the sections during the cutting of immunohistochemical preparations. The expression of E-cadherin in tumor emboli was significantly higher (p<0.001) than in tumor tissue. At the same time, no cases identified where the level of E-cadherin decreased in emboli compared to the tumor. A significant increase in the expression of E-cadherin in tumor emboli compared to the primary tumor was noted for all histological types according to WHO 2019, for intermediate and diffuse types according to the P. Lauren classification (p<0.001). Comparison of expression in emboli and tumors for neoplasms with different depths of invasion (T), different stages and different localizations did not reveal statistically significant differences. An increase in the expression of E-cadherin in emboli compared to tumors was characterized by a higher level of significance in the presence of metastases (N1, N2, N3a, N3b; p<0.001) than in the absence of metastases (N0; p=0.016).

CONCLUSION

The study revealed a statistically significant increase in the expression of E-cadherin in tumor emboli compared to the primary tumor, which is evidence of its important role in maintaining the integrity of emboli and tumor dissemination.

Keywords:

E-cadherin
gastric cancer
emboli
expression
immunohistochemistry

Authors:

Danilova N.V.

Lomonosov Moscow State University

Mikhailov I.A.

Center for Expertise and Quality Control of Medical Care;
Lomonosov Moscow State University

Oleynikova N.A.

Lomonosov Moscow State University

Polushkina T.V.

Lomonosov Moscow State University

Received:

26.02.2021

Accepted:

05.03.2021

Close metadata

References:

  1. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis CA, Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo C, Oliveira C, Seruca R. Epithelial E- P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012;1826(2):297-311.  https://doi.org/10.1016/j.bbcan.2012.05.002
  2. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005;6(8):622-634.  https://doi.org/10.1038/nrm1699
  3. Halbleib,J.M, Nelson WJ. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev. 2006;20(23): 3199-3214. https://doi.org/10.1101/gad.1486806
  4. Lien WH, Klezovitch O, Vasioukhin V. Cadherin-catenin proteins in vertebrate development. Curr Opin Cell Biol. 2006;18(5):499-506.  https://doi.org/10.1016/j.ceb.2006.07.001
  5. Hulpiau P, van Roy F. Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol. 2009;41(2):349-369.  https://doi.org/10.1016/j.biocel.2008.09.027
  6. Redies C, Vanhalst K, Roy F. δ-Protocadherins: unique structures and functions. Cell Mol Life Sci. 2005;62(23):2840-2852. https://doi.org/10.1007/s00018-005-5320-z
  7. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65(23):3756-3788. https://doi.org/10.1007/s00018-008-8281-1
  8. Blaschuk OW, Sullivan R, David S, Pouliot Y. Identification of a cadherin cell adhesion recognition sequence. Dev Biol. 1990; 139(1):227-229.  https://doi.org/10.1016/0012-1606(90)90290-y
  9. Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778(3):660-669.  https://doi.org/10.1016/j.bbamem.2007.07.012
  10. Kobielak A, Fuchs E. Alpha-catenin: at the junction of intercellular adhesion and actin dynamics. Nat Rev Mol Cell Biol. 2004;5(8): 614-625.  https://doi.org/10.1038/nrm1433
  11. Perez-Moreno M, Fuchs E. Catenins: keeping cells from getting their signals crossed. Dev Cell. 2006;11(5):601-612.  https://doi.org/10.1016/j.devcel.2006.10.010
  12. Reynolds AB, Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene. 2004;23(48):7947-7956. https://doi.org/10.1038/sj.onc.1208161
  13. Scott JA, Yap AS. Cinderella no longer: alpha-catenin steps out of cadherin’s shadow. J Cell Sci. 2006;119(Pt22):4599-4605. https://doi.org/10.1242/jcs.03267
  14. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci Suppl. 1993;17(Suppl):155-158.  https://doi.org/10.1242/jcs.1993.supplement_17.22
  15. Makrilia N, Kollias A, Manolopoulos L, Syrigos K. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest. 2009;27(10):1023-1037. https://doi.org/10.3109/07357900902769749
  16. Mareel M, Oliveira MJ, Madani I. Cancer invasion and metastasis: interacting ecosystems. Virchows Arch. 2009;454(6):599-622.  https://doi.org/10.1007/s00428-009-0784-0
  17. Van Aken E, De Wever O, Correia da Rocha AS, Mareel M. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch. 2001;439(6):725-751.  https://doi.org/10.1007/s004280100516
  18. Berx G, van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol. 2009;1(6):a003129. https://doi.org/10.1101/cshperspect.a003129
  19. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004;4(2):118-132.  https://doi.org/10.1038/nrc1276
  20. Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci. 2004;1014:155-163.  https://doi.org/10.1196/annals.1294.016
  21. Strumane K, Berx G, Van Roy F. Cadherins in cancer. Handb Exp Pharmacol. 2004(165):69-103.  https://doi.org/10.1007/978-3-540-68170-0_4
  22. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol. 1989;108(6):2435-2447.
  23. Mareel MM, Behrens J, Birchmeier W, De Bruyne GK, Vleminckx K, Hoogewijs A, Fiers WC, Van Roy FM. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer. 1991;47(6):922-928.  https://doi.org/10.1002/ijc.2910470623
  24. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998;392(6672):190-193.  https://doi.org/10.1038/32433
  25. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991;66(1):107-119.  https://doi.org/10.1016/0092-8674(91)90143-m
  26. Luo J, Sharma N, Seftor EA, De Larco J, Heidger PM, Hendrix MJ, Lubaroff DM. Heterogeneous expression of invasive and metastatic properties in a prostate tumor model. Pathol Oncol Res. 1997;3(4):264-271.  https://doi.org/10.1007/bf02904285
  27. Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsun Y, Muto T, Hirohashi S. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 1996;24(6):1460-1467. https://doi.org/10.1053/jhep.1996.v24.pm0008938181
  28. Kim J, Yu W, Kovalski K, Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell. 1998;94(3):353-362.  https://doi.org/10.1016/s0092-8674(00)81478-6
  29. Van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res. 2011;728(1-2): 23-34.  https://doi.org/10.1016/j.mrrev.2011.05.002
  30. Alpaugh ML, Tomlinson JS, Kasraeian S, Barsky SH. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene. 2002;21(22):3631-3643. https://doi.org/10.1038/sj.onc.1205389
  31. Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH. A novel human xenograft model of inflammatory breast cancer. Cancer Res. 1999;59(20):5079-5084.
  32. Kleer CG, van Golen KL, Braun T, Merajver SD. Persistent E-cadherin expression in inflammatory breast cancer. Mod Pathol. 2001;14(5):458-464.  https://doi.org/10.1038/modpathol.3880334
  33. Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 2001;61(13):5231-5241.
  34. Ye Y, Tellez JD, Durazo M, Belcher M, Yearsley K, Barsky SH. E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking. Anticancer Res. 2010;30(10):3903-3910.
  35. Kang HG, Jenabi JM, Zhang J, Keshelav N, Shimada H, May WA, Ng T, Reynolds CP, Triche TJ, Sorensen PH. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 2007;67(7):3094-3105. https://doi.org/10.1158/0008-5472.can-06-3259
  36. Kantak SS, Kramer RH. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem. 1998;273(27):16953-16961. https://doi.org/10.1074/jbc.273.27.16953
  37. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994;54(14):3845-3852.
  38. Becker KF, Kremmer E, Eulitz M, Becker I, Handschuh G, Schuhmacher C, Müller W, Gabbert HE, Ochiai A, Hirohashi S, Höfler H. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Am J Pathol. 1999;155(6):1803-1809. https://doi.org/10.1016/s0002-9440(10)65497-1
  39. Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012;228(1):31-44.  https://doi.org/10.1002/path.4032
  40. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20(12):1525-1528. https://doi.org/10.1038/sj.onc.1204234
  41. Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW, Deshpande V, Mino-Kenudson M, Srivastava A, Lennerz JK, Hong TS, Kwak EL, Lauwers GY. A protein and mRNA expression-based classification of gastric cancer. Mod Pathol. 2016;29(7):772-784.  https://doi.org/10.1038/modpathol.2016.55
  42. Rodriguez FJ, Lewis-Tuffin LJ, Anastasiadis PZ. E-cadherin’s dark side: possible role in tumor progression. Biochim Biophys Acta. 2012;1826(1):23-31.  https://doi.org/10.1016/j.bbcan.2012.03.002
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.